Literature DB >> 11592599

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis.

G Paizis1, R E Gilbert, M E Cooper, P Murthi, J M Schembri, L L Wu, J R Rumble, D J Kelly, C Tikellis, A Cox, R A Smallwood, P W Angus.   

Abstract

BACKGROUND/AIMS: The aim of this study was to investigate whether in the liver, as in other tissues, there is evidence that angiotensin II, acting via the angiotensin II type 1 receptor (AT1-R), plays a role in fibrogenesis.
METHODS: Sprague-Dawley rats were divided into three groups; sham, bile duct ligated (BDL) and BDL + AT1-R antagonist, irbesartan. Real time RT-PCR was utilised to assess gene expression of the AT1 receptor, TGF-beta1 and alpha1 (I) collagen in the liver. TGF-beta1 and alpha1 (I) collagen mRNA expression and localisation were also assessed by in situ hybridisation. TGF-beta1 activity was assessed by using the TGF-beta inducible gene product betaig-h3. Fibrosis was assessed by the Knodell scoring system, tissue hydroxyproline content and picro-sirius red staining.
RESULTS: Real time RT-PCR revealed that there was a 6-fold up-regulation in AT1 receptor expression in BDL animals compared with shams. This was associated with marked increases in TGF-beta1, betaig-h3 and alpha1 (I) collagen gene expression which were attenuated by AT1-RA treatment. However, AT1-RA therapy produced no significant change in liver histology or hydroxyproline content.
CONCLUSIONS: These results suggest that in the liver angiotensin II may play an important role in the fibrogenic response to injury. However, whether treatment with an AT1-RA will be of therapeutic benefit remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592599     DOI: 10.1016/s0168-8278(01)00146-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  45 in total

1.  Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms.

Authors:  Xiao-Ling Wu; Wei-Zheng Zeng; Pi-Long Wang; Chun-Tao Lei; Ming-De Jiang; Xiao-Bin Chen; Yong Zhang; Hui Xu; Zhao Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Authors:  Luis F Reyes; Marcos I Restrepo; Cecilia A Hinojosa; Nilam J Soni; Antonio Anzueto; Bettina L Babu; Norberto Gonzalez-Juarbe; Alejandro H Rodriguez; Alejandro Jimenez; James D Chalmers; Stefano Aliberti; Oriol Sibila; Vicki T Winter; Jacqueline J Coalson; Luis D Giavedoni; Charles S Dela Cruz; Grant W Waterer; Martin Witzenrath; Norbert Suttorp; Peter H Dube; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

3.  Losartan may inhibit the progression of liver fibrosis in chronic HCV patients.

Authors:  Zakaria A Salama; Ahmed Sadek; Ahmed M Abdelhady; Samar Kamal Darweesh; Shereif Ahmed Morsy; Gamal Esmat
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

4.  Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis.

Authors:  Cansel Türkay; Ozlem Yönem; Sema Arici; Ayhan Koyuncu; Mehmet Kanbay
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

5.  Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.

Authors:  Yao Hong Wei; Li Jun; Chen Ji Qiang
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

6.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

Authors:  Ramon Bataller; Robert F Schwabe; Youkyung H Choi; Liu Yang; Yong Han Paik; Jeffrey Lindquist; Ting Qian; Robert Schoonhoven; Curt H Hagedorn; John J Lemasters; David A Brenner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 7.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

8.  Reversal of liver fibrosis.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 9.  Renin-angiotensin system in the pathogenesis of liver fibrosis.

Authors:  Regina Maria Pereira; Robson Augusto Souza dos Santos; Filipi Leles da Costa Dias; Mauro Martins Teixeira; Ana Cristina Simões e Silva
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

10.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.